The single-cell analysis market is expected to reach $3.59 billion by 2022 from $1.67 billion in 2017, at a CAGR of 16.5%. On the other hand, the high cost of single-cell analysis instruments may hinder the growth of the market in the coming years
Access full report on Single-cell Analysis Market @
The single cell analysis market is highly competitive with the presence of major players. Following list show all major players
Merck KGaA (Germany), Becton, Dickinson and Company (U.S.), Promega Corporation (U.S.), Danaher Corporation (U.S.), General ElectricCompany (U.K.), Thermo Fisher Scientific Inc. (U.S.), Miltenyi Biotec (Germany), Illumina, Inc. (U.S.), Bio-Rad Laboratories, Inc.(U.S.), Fluidigm Corporation (U.S.), NanoString Technologies, Inc. (U.S.), Agilent Technologies (U.S.), Abcam Plc (U.S.), NuGEN Technologies Inc. (U.S.), LumaCyte (U.S.), PluriSelect Life Science UG & Co. KG (Germany), Sysmex Partec(U.S.), Bio-Techne Corporation (U.S.), Promega Corporation (U.S.), 10x Genomics(U.S.), WaferGen Bio-systems, Inc. (U.S.), Bruker (U.S.), and Fluxion Biosciences(U.S.) are some of the other leading companies operating in the global single-cell analysis market.
Technological advancements in single-cell analysis products, increasing government funding for cell-based research, growing biotechnology and biopharmaceutical industries, wide applications of single-cell analysis in cancer research, growing focus on personalized medicine, and increasing incidence and prevalence of chronic and infectious diseases are driving the growth of the single-cell analysis market.
Request for complimentary paper @
Target Audience for this Report:
- Research and consulting firms
- Single-cell analysis product manufacturers
- Single-cell analysis service providers
- Clinical research organizations (CROs)
- Hospitals and diagnostic laboratories
- Research & academic laboratories and institutes
- Life science instrumentation and reagents companies
- Business research and consulting firms
- Venture capitalists
- Government bodies
Scope of the Report
This report categorizes the market into following segments and subsegments:
Single-cell Analysis Market, By Products
- Assay Kits
- Cell-based Assays
- Other Consumables
- Flow Cytometers
- NGS Systems
- PCR Instruments
- Cell Counters
- HCS Systems
- Cell Microarrays
Single-cell Analysis Market, By Cell Type
- Human Cells
- Animal Cells
- Microbial Cells
Single-cell Analysis Market, By Technique
- Flow Cytometry
- Mass Spectrometry
- Other Techniques
Based on product, the single-cell analysis market is segmented into consumables and instruments. Consumables are expected to register the highest CAGR during the forecast period. Consumables are further segmented into beads, micro plates, reagents, assay kits, and other consumables, whereas, instruments are further segmented into flow cytometers, NGS systems, PCR instruments, HCS systems, microscopes, cell counters, spectrophotometers, cell microarrays, and other instruments. Players from the market are increasingly focusing on technological advancements and product development to launch efficient cytometry instruments which is driving the growth of the segment.
Browse complete report on Single-cell Analysis Market by Product (Consumables and Instruments), Cell Type (Human and Animal), Technique (Flow Cytometry, NGS, PCR, and Mass Spectrometry), Application (Cancer, Neurology, NIPD, IVF, and CTCs), End User – Global Forecasts to 2022 at
In 2017, North America is expected to account for the largest share of the single-cell analysis market. Factors such as increasing collaborations among prominent players, technological advancements and expanding biotechnology and pharmaceutical industries are supporting the growth of the single-cell analysis market in this region.
Asian region is expected to register the highest CAGR during the forecast period. The large population in China and India, rising geriatric population, and increasing incidence of chronic diseases are the major factors driving the growth of the Asian market.